Julie Teruya-Feldstein Selected Research

Julie Teruya-Feldstein Research Topics

Disease

64	Neoplasms (Cancer) 01/2022 - 02/2002
22	Lymphoma (Lymphomas) 01/2020 - 09/2002
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2019 - 03/2003
9	B-Cell Lymphoma (Lymphoma, B Cell) 05/2013 - 03/2003
8	Carcinogenesis 09/2014 - 01/2005
7	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2006
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2015 - 02/2002
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2014 - 05/2002
6	Leukemia 04/2015 - 11/2010
6	Hodgkin Disease (Hodgkin's Disease) 02/2014 - 09/2004
4	Breast Neoplasms (Breast Cancer) 10/2012 - 03/2010
3	Multiple Myeloma 12/2021 - 09/2003
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 04/2010
3	Immunoglobulin Light-chain Amyloidosis 01/2008 - 05/2006
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 02/2014
2	Pancytopenia 07/2019 - 05/2004
2	Primary Myelofibrosis (Myelosclerosis) 01/2018 - 03/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2015 - 10/2014
2	Splenomegaly 03/2015 - 07/2009
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2013 - 05/2004
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2013 - 07/2006
2	T-Cell Lymphoma (Lymphoma, T Cell) 09/2013 - 10/2009
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2013 - 07/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2013 - 10/2009
2	Melanoma (Melanoma, Malignant) 02/2013 - 03/2005
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2012 - 09/2003
2	Carcinoma (Carcinomatosis) 02/2012 - 04/2006
2	Hyperplasia 10/2011 - 05/2002
2	Hypoxia (Hypoxemia) 03/2011 - 08/2006
2	Lung Neoplasms (Lung Cancer) 03/2010 - 07/2006
2	Adenocarcinoma of Lung 03/2010 - 10/2009
2	Prostatic Neoplasms (Prostate Cancer) 08/2009 - 09/2008
2	Amyloidosis 10/2007 - 05/2006
2	Colorectal Neoplasms (Colorectal Cancer) 04/2006 - 10/2005
2	Plasmacytoma 09/2003 - 07/2003
1	Movement Disorders (Movement Disorder) 12/2021
1	Parkinsonian Disorders (Parkinsonism) 12/2021
1	Snoring 07/2021
1	Airway Obstruction (Choking) 07/2021
1	Pharyngitis (Sore Throat) 07/2021
1	Dyspnea (Shortness of Breath) 07/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021
1	Intestinal Failure 01/2021
1	Fibrosis (Cirrhosis) 01/2020

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 10/2016 - 05/2002
8	Rituximab (Mabthera)FDA Link 01/2020 - 09/2002
7	Phosphotransferases (Kinase)IBA 11/2015 - 07/2006
7	MicroRNAs (MicroRNA)IBA 02/2014 - 10/2007
6	Pharmaceutical PreparationsIBA 01/2018 - 10/2005
5	AntibodiesIBA 07/2019 - 11/2004
5	Transcription Factors (Transcription Factor)IBA 01/2016 - 10/2007
5	Monoclonal AntibodiesIBA 08/2012 - 02/2002
5	TOR Serine-Threonine KinasesIBA 03/2009 - 08/2005
4	Biomarkers (Surrogate Marker)IBA 07/2012 - 08/2006
4	Methotrexate (Mexate)FDA LinkGeneric 02/2006 - 09/2003
3	Janus Kinase InhibitorsIBA 01/2020 - 03/2015
3	CytokinesIBA 01/2018 - 10/2011
3	Oncogene Proteins (Oncogene Protein)IBA 09/2014 - 08/2005
3	Anaplastic Lymphoma KinaseIBA 09/2013 - 07/2006
3	AntigensIBA 02/2013 - 10/2002
3	Bortezomib (Velcade)FDA Link 07/2012 - 05/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2010 - 09/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2010 - 09/2003
3	Biological ProductsIBA 12/2009 - 03/2004
3	ErbB Receptors (EGF Receptor)IBA 03/2009 - 10/2005
2	RNA Splicing FactorsIBA 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2012
2	Chimeric Antigen ReceptorsIBA 12/2021 - 10/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 06/2014
2	EnzymesIBA 01/2018 - 07/2012
2	LipidsIBA 01/2018 - 06/2014
2	ruxolitinibIBA 11/2015 - 03/2015
2	Protein Isoforms (Isoforms)IBA 09/2014 - 02/2002
2	Cadherins (E-Cadherin)IBA 02/2014 - 03/2010
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2013 - 08/2007
2	NucleophosminIBA 04/2010 - 04/2008
2	Messenger RNA (mRNA)IBA 03/2010 - 03/2010
2	Everolimus FDA Link 03/2009 - 09/2008
2	Sirolimus (Rapamycin)FDA Link 09/2008 - 08/2008
2	Mechanistic Target of Rapamycin Complex 1IBA 09/2008 - 08/2008
2	Eukaryotic Initiation Factor-4EIBA 08/2008 - 12/2007
2	Melphalan (Alkeran)FDA LinkGeneric 01/2008 - 10/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2007 - 01/2006
2	Thalidomide (Thalomid)FDA Link 10/2007 - 01/2006
2	trans-sodium crocetinate (crocetin)IBA 08/2007 - 08/2005
2	Proteasome InhibitorsIBA 08/2006 - 05/2006
2	Drug CombinationsIBA 05/2006 - 01/2006
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2006 - 09/2003
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021
1	idecabtagene vicleucelIBA 12/2021
1	B-Cell Maturation AntigenIBA 12/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2021

Therapy/Procedure

29	Therapeutics 12/2021 - 09/2002
10	Drug Therapy (Chemotherapy) 04/2015 - 09/2003
5	Stem Cell Transplantation 01/2010 - 09/2002
2	Transplantation 01/2020 - 10/2013
2	Splenectomy 07/2009 - 05/2009
1	Tracheostomy 07/2021
1	Total Parenteral Nutrition 01/2021
1	Immunotherapy 01/2020